Vanmiksan: an antibiotic for severe infections
Vanmixan is an antibiotic that is used to treat severe infectious and inflammatory diseases caused by pathogens sensitive to vancomycin. It belongs to a group of antibiotics of different classes and is produced by Sanofi Winthrop Industry in France.
The international name of the drug is Vancomycin, and it is also known under synonyms: Vancoled, Vancomycin Qualimed, Vancomycin-Teva, Vancocin, Vero-Vancomycin, Editsin. The dosage form of Vanmiksan is lyophilized powder for the preparation of an injection solution of 500 mg.
The active ingredient of the drug is Vancomycin. It is effective for severe infections that cannot be treated with other antibiotics such as penicillins, cephalosporins and others.
The drug is indicated in the treatment of sepsis, endocarditis, pneumonia, lung abscess, osteomyelitis, infections of the skin and skin structures, pseudomembranous colitis caused by Clostridium difficile, enterocolitis, meningitis.
However, before using Vanmiksan, you must ensure that there are no contraindications. Contraindications include hypersensitivity to the drug, acoustic neuritis, pregnancy in the first trimester. In the presence of severe kidney damage, hearing impairment, pregnancy in the second and third trimesters, as well as breastfeeding, the use of this drug should be limited.
Vanmixan has a number of side effects that can manifest itself in the form of nausea, vomiting, bitter taste in the mouth, chills, itching, urticaria, Stevens-Johnson syndrome. After intravenous administration of the drug, thrombophlebitis, vasculitis, fever, neutropenia, eosinophilia, thrombocytopenia, and sometimes anaphylactoid reactions may occur.
With rapid intravenous administration, a burning sensation, redness of the upper body (red neck syndrome), pain and muscle spasms in the back and chest, arterial hypotension, dizziness, and tinnitus may occur. In rare cases, oto- and nephrotoxicity may occur, which is manifested by decreased hearing up to deafness and impaired renal function.
Therefore, the use of Vanmiksan should be carried out only as prescribed by a doctor, in compliance with the dosage and recommendations for use. In addition, caution should be exercised when using the drug in elderly patients and patients with impaired renal function.
Overall, Vanmixan is an effective antibiotic for treating severe infections, but its use should be limited to cases where other antibiotics are not effective or cannot be used for some reason. In addition, it is necessary to take into account possible side effects and contraindications when using the drug.